Bob, This company was nearly bankrupted, and its stoc was traded @ $2.00 just 10 months ago. If I were you, I would not even pay anything more than $3.00. You just need to be patient... Good luck to you
Are you serious? What biotech/pharma venture hasn't been slammed at one point or another because of a bad result? NBIX is going up for a good reason. They are undervalued based on the prospects of their endometriosis candidate which is clearly working at this stage. There are not many companies valued this low with a candidate this good. Abbott is a great partner. I'm not even thinking about the pipeline that might have a winner or two. I say strong buy recommendations are coming very soon. This trades in the double digits within the next couple of months in my opinion.
After listening to the Q3 conference call and the PJ presentation, I liked what I heard. They tell a good story. They have clearly laid out their near term news flow. They have indicated that for the next calendar year they hope to be cash neutral. I am hoping the buy side analysts will take notice.
Take this for what it is worth; I am a bag holder from their failed sleeping pill. But I have been averaging down, and I am excited about their pipeline. Good Luck,